Literature DB >> 7527133

Increase in bcl-2 oncoprotein and the tolerance to ischemia-induced neuronal death in the gerbil hippocampus.

K Shimazaki1, A Ishida, N Kawai.   

Abstract

We studied the expression of bcl-2 oncoprotein in the gerbil hippocampus after transient ischemia. Immunostaining using monoclonal antibody raised against bcl-2 oncoprotein revealed intense immunoreactivity in the CA1 area following 2 min of ischemia, which induced tolerance to subsequent ischemia and prevented delayed neuronal death (DND). Following ischemia for 5 min, however, bcl-2 oncoprotein immunoreactivity was decreased, reflecting neuronal death in the CA1 area. However, pretreatment with ischemia of 2 min that prevented DND due to subsequent ischemia for 5 min, showed increased immunoreactivity. On the other hand, following 1 min of ischemia which failed to induce tolerance, no increase in the bcl-2 oncoprotein was observed. The results evidenced that expression of bcl-2 oncoprotein in the CA1 area following brief ischemia is closely related to the acquisition of resistance to DND.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527133     DOI: 10.1016/0168-0102(94)90026-4

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  28 in total

1.  Phosphorylation of Bcl-2 and Bax proteins during hypoxia in newborn piglets.

Authors:  Q M Ashraf; S A Zanelli; O P Mishra; M Delivoria-Papadopoulos
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

Review 2.  The adaptive effects of hypoxic preconditioning of brain neurons.

Authors:  M O Samoilov; E V Lazarevich; D G Semenov; A A Mokrushin; E I Tyul'kova; D Yu Romanovskii; E A Milyakova; K N Dudkin
Journal:  Neurosci Behav Physiol       Date:  2003-01

3.  Oxidative stress activates transcription factor NF-kB-mediated protective signaling in primary rat neuronal cultures.

Authors:  Ella Kratsovnik; Yael Bromberg; Oded Sperling; Esther Zoref-Shani
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

4.  Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene.

Authors:  G Bilbao; J L Contreras; D E Eckhoff; G Mikheeva; V Krasnykh; J T Douglas; F T Thomas; J M Thomas; D T Curiel
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

5.  Evidence for a role of second pathophysiological stress in prevention of delayed neuronal death in the hippocampal CA1 region.

Authors:  Jozef Burda; Milina Matiasová; Miroslav Gottlieb; Viera Danielisová; Miroslava Némethová; Lidia Garcia; Matilde Salinas; Rastislav Burda
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

6.  Ribonuclease improves the state of hippocampal sections in the post-ischemic period.

Authors:  I E Kudryashov; I V Kudryashova; V V Raevskii
Journal:  Neurosci Behav Physiol       Date:  1998 Jul-Aug

7.  Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia.

Authors:  J Chen; T Nagayama; K Jin; R A Stetler; R L Zhu; S H Graham; R P Simon
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

8.  Localization of Bax and Bcl-2 proteins, regulators of programmed cell death, in the human central nervous system.

Authors:  A Hara; Y Hirose; A Wang; N Yoshimi; T Tanaka; H Mori
Journal:  Virchows Arch       Date:  1996-11       Impact factor: 4.064

9.  Down-regulation of parkin protein in transient focal cerebral ischemia: A link between stroke and degenerative disease?

Authors:  Thorsten Mengesdorf; Poul H Jensen; Gunter Mies; Christoph Aufenberg; Wulf Paschen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

10.  Effect of noradrenalin and EGb 761 pretreatment on the ischemia-reperfusion injured spinal cord neurons in rabbits.

Authors:  Eva Mechírová; Iveta Domoráková; Marianna Danková; Viera Danielisová; Jozef Burda
Journal:  Cell Mol Neurobiol       Date:  2009-03-17       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.